YB

Yogita Bhati

Active Director Director DIN 07716392
DIN 07716392 First appointment Feb 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value •••• Premium profile

About Yogita Bhati

Data last updated:

Yogita Bhati is a Director at Manavta Hospitals Private Limited (since 2017). The company operates in Healthcare. Manavta Hospitals Private Limited reported revenue of ₹16.40 Cr (FY 2025).

DIN 07716392
Primary Designation Director
Industry Healthcare
First Appointment 10 Feb 2017
Oldest Company Age 9 yrs
Largest company Manavta Hospitals Private Limited · ₹16.40 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Manavta Hospitals Private Limited U85320HR2017PTC067651
Director10 Feb 20172017₹16.40 Cr (FY 2025)Active

Board colleagues of Yogita Bhati

Directorship timeline

Open interactive timeline →
Manavta Hospitals Private Limited
Premium access

Shareholding and investment profile for Yogita Bhati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogita Bhati

Yogita Bhati currently holds 1 directorship: Manavta Hospitals Private Limited (Director, since 10 Feb 2017, revenue ₹16.40 Cr (FY 2025)).

Yogita Bhati was first appointed on 10 Feb 2017 as Director at Manavta Hospitals Private Limited.

The current boards of Yogita Bhati's companies include Ghufran Akhtar Nomani (Manavta Hospitals Private Limited), Munesh Bhati (Manavta Hospitals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available